Cargando…

High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019

The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly in China. Until now, no definite effective treatment has been identified. We reported on 3 patients with severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Wei, Liu, Xiaosheng, Bai, Tao, Fan, Hongwei, Hong, Ke, Song, Hui, Han, Yang, Lin, Ling, Ruan, Lianguo, Li, Taisheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111600/ https://www.ncbi.nlm.nih.gov/pubmed/32258207 http://dx.doi.org/10.1093/ofid/ofaa102

Ejemplares similares

High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
por: Cao, Wei, et al.
Publicado: (2021)

Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
por: Cao, Wei, et al.
Publicado: (2021)

High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
por: Liu, Xiaosheng, et al.
Publicado: (2020)

Benefits of high-dose intravenous immunoglobulin on mortality in patients with severe COVID-19: An updated systematic review and meta-analysis
por: Liu, Xiaosheng, et al.
Publicado: (2023)

Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease
por: Danieli, Maria Giovanna, et al.
Publicado: (2021)

High-dose intravenous immunoglobulin therapy for novel coronavirus disease 2019: a brief report of two cases
por: Erdogan, Cem, et al.
Publicado: (2020)

Severe Coronavirus Disease 2019 That Recovered from Respiratory Failure by Treatment That Included High-dose Intravenous Immunoglobulin
por: Suzuki, Yasuhito, et al.
Publicado: (2020)

Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019
por: Sakoulas, George, et al.
Publicado: (2020)

Intravenous immunoglobulin as a therapeutic option for patients with worsening COVID-19 under rituximab
por: Vasconcelos, Joana, et al.
Publicado: (2021)

Characteristics of the Coronavirus Disease 2019 and related Therapeutic Options
por: Huang, Boxuan, et al.
Publicado: (2020)

Hydroxychloroquine at usual doses as an option for coronavirus disease 2019 treatment
por: Carbillon, Lionel, et al.
Publicado: (2021)

Diagnostic approaches and potential therapeutic options for coronavirus disease 2019
por: Khan, Z., et al.
Publicado: (2020)

Targeting Macrophages as a Therapeutic Option in Coronavirus Disease 2019
por: Gracia-Hernandez, Maria, et al.
Publicado: (2020)

May early intervention with intravenous immunoglobulin pose a potentially successful treatment for Ebola virus infection?
por: Ge, Ying, et al.
Publicado: (2014)

Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 Pandemic( )
por: Farcet, Maria R, et al.
Publicado: (2021)

Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin
por: Aljaberi, Rana, et al.
Publicado: (2020)

Dose Optimization of Hydroxychloroquine for Coronavirus Infection 2019: Do Blood Concentrations Matter?
por: Ippolito, Matthew M, et al.
Publicado: (2020)

Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach
por: Sarma, Phulen, et al.
Publicado: (2020)

Prolonged presence of viral nucleic acid in clinically recovered COVID-19 patients was not associated with effective infectiousness
por: Hong, Ke, et al.
Publicado: (2020)

The clinical response of West Nile virus neuroinvasive disease to intravenous immunoglobulin therapy
por: Shimoni, Zvi, et al.
Publicado: (2012)

Therapeutic Options for Coronavirus Disease 2019 (COVID-19): Where Are We Now?
por: Bae, Esther Y., et al.
Publicado: (2021)

High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease
por: Hoffmann, Jochen H. O., et al.
Publicado: (2019)

Intravenous immunoglobulin immunotherapy for coronavirus disease‐19 (COVID‐19)
por: Galeotti, Caroline, et al.
Publicado: (2020)

Isoagglutinin‐reduced immunoglobulin retains efficacy in mouse models of immune thrombocytopenia and rheumatoid arthritis and is less likely to cause intravenous immunoglobulin–associated hemolysis
por: Cen, Selena Y., et al.
Publicado: (2019)

Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19
por: Zhou, Zhi-Guo, et al.
Publicado: (2020)

Potential benefit of high-dose intravenous vitamin C for coronavirus disease 2019 pneumonia
por: Zhao, Bing, et al.
Publicado: (2022)

High-dose intravenous vitamin C attenuates hyperinflammation in severe coronavirus disease 2019
por: Xia, Guozhi, et al.
Publicado: (2021)

Pediatric Hereditary Neuralgic Amyotrophy: Successful Treatment With Intravenous Immunoglobulin and Insights Into SEPT9 Pathogenesis
por: Chuk, Raymond, et al.
Publicado: (2016)

Therapeutic Potential of Intravenous Immunoglobulin in Acute Brain Injury
por: Thom, Vivien, et al.
Publicado: (2017)

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
por: Galeotti, Caroline, et al.
Publicado: (2010)

High-dose intravenous immunoglobulins as a therapeutic option in critical illness polyneuropathy accompanying SARS-CoV-2 infection: A case-based review of the literature (Review)
por: Stoian, Adina, et al.
Publicado: (2021)

PRACTICAL ISSUES FOR CLINICIANS USING HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN
por: Khan, S, et al.
Publicado: (2011)

High dose intravenous immunoglobulin may be complicated by myocardial infarction
por: Vinod, Kolar Vishwanath, et al.
Publicado: (2014)

High-dose intravenous immunoglobulin therapy for eosinophilic granulomatosis with polyangiitis
por: Tsurikisawa, Naomi, et al.
Publicado: (2014)

Streptococcal throat: Therapeutic options and macrolide resistance
por: Al-Hamad, Arif M.
Publicado: (2015)

Impact of Site of Care on Infection Rates Among Patients with Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin Therapy
por: Wasserman, Richard L., et al.
Publicado: (2017)

Coronaviruses — drug discovery and therapeutic options
por: Zumla, Alimuddin, et al.
Publicado: (2016)

Potential therapeutic approach of intravenous immunoglobulin against COVID-19
por: Kolahchi, Zahra, et al.
Publicado: (2021)

Acitretin as a Therapeutic Option for Chronic Hand Eczema
por: Song, Margaret, et al.
Publicado: (2017)

Diagnostic options for coronavirus disease 2019 (COVID-19)
por: Xiao, Yuanyuan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c04350j6ssj1tkcban706eg3ed